- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 279 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- December 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- January 2025
- 187 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- February 2025
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- August 2024
- 141 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 263 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 250 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- July 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 155 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- June 2022
- 90 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- November 2023
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 85 Pages
Germany
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 77 Pages
South Korea
From €4516EUR$4,750USD£3,794GBP

Digital Breast Tomosynthesis (DBT), also known as 3D mammography, is a specialized imaging technology used within the field of mammography for breast cancer screening and diagnosis. Using X-ray technology, DBT takes multiple images of the breast from different angles, assembling them to create a three-dimensional reconstruction of the breast. This advanced imaging technique allows for more accurate detection of breast lesions and reduces the number of false positives compared to traditional 2D mammography. The introduction of DBT has been an advancement in women's healthcare, particularly in the detection of breast cancer in its early stages, which is crucial for successful treatment and improved outcomes.
In the landscape of breast imaging, the adoption of DBT has gradually complemented or, in some cases, replaced traditional mammography systems due to its enhanced imaging capabilities. While 2D mammograms remain in use, the demand for 3D imaging solutions continues to grow, as healthcare providers and patients seek more accurate diagnostic tools.
Some of the prominent players in the Digital Breast Tomosynthesis market include Hologic, Inc., GE Healthcare, Siemens Healthineers, and Fujifilm Holdings Corporation. These companies have invested in the research and development of advanced DBT systems and have a considerable presence in the field, offering a range of mammography products to healthcare providers around the world. Show Less Read more